ER

Saladax Biomedical appoints Myslinski as CCO

Friday, November 16, 2012 12:18 PM

Saladax Biomedical, a Bethlehem, Penn.-based privately held company that develops diagnostic assays for the practical delivery of personalized medicine, has appointed Mark D. Myslinski as senior vice president and chief commercial officer.

More... »

Protein predicts diabetes risk many years in advance

Wednesday, November 14, 2012 03:05 PM

When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be put in place.

More... »

PerkinElmer acquires Shanghai Haoyuan Biotech

Wednesday, November 14, 2012 11:36 AM

PerkinElmer, a global technology company focused on the health and safety of people and the environment, has completed the acquisition of Shanghai Haoyuan Biotech, a China-based infectious disease diagnostics company. The acquisition extends PerkinElmer's capabilities into nucleic acid blood screening and in the growing molecular clinical diagnostics market in China.

More... »

Pearl Therapeutics raises $65M Series D to start PT003 phase III trial

Wednesday, November 14, 2012 10:48 AM

Pearl Therapeutics, a Redwood City, Calif.-based privately held company developing combination therapies for the treatment of highly prevalent respiratory diseases, has raised a $65 million Series D financing from current investors.

More... »

GNS Healthcare, Dana-Farber, Mount Sinai to build computer model of multiple myeloma

Tuesday, November 13, 2012 01:57 PM

GNS Healthcare, a healthcare data analytics company, has entered into a collaboration with Dana-Farber Cancer Institute and the Mount Sinai School of Medicine to create a data-driven computer model of multiple myeloma, the second most common blood cancer in the U.S.

More... »

Boehringer Ingelheim launches Hep C online resource

Tuesday, November 13, 2012 01:39 PM

Boehringer Ingelheim has launched HepCRedefined.com, an online portal to help improve the lives of those living with the hepatitis C virus (HCV) through education, information and understanding. The portal aims to redefine the HCV journey by providing downloadable and shareable resources to healthcare providers, advocates, caregivers and patients.

More... »

DiscoveRx acquires BioSeek

Tuesday, November 13, 2012 12:40 PM

DiscoveRx, a privately held, venture-backed company based in Fremont, Calif., has agreed to acquire BioSeek, a drug discovery services provider based in South San Francisco.

More... »

AG Mednet licenses Columbia University software to reduce protocol amendments, unnecessary costs

Monday, November 12, 2012 09:00 AM

Unnecessary procedures and amendments to clinical trial protocols cost sponsors more than $5 billion per year and are responsible for 20% of clinical trial budgets, according to recent research. To help reduce these costs and create zero-delay clinical trials, AG Mednet has licensed from Columbia University advanced image analysis technology developed by Drs. Lawrence Schwartz, Binsheng Zhao and Yongqiang Tan at Columbia University Medical Center.

More... »

Orwin joins Array BioPharma’s board of directors

Friday, November 9, 2012 02:29 PM

Array BioPharma, a biopharmaceutical company focused on targeted small molecule drugs for the treatment of cancer, has appointed John A. Orwin, CEO of Affymax, to Array's board of directors as part of its continued evolution toward late-stage development and commercialization.

More... »

Bausch + Lomb to acquire Technolas Perfect Vision

Friday, November 9, 2012 11:46 AM

Bausch + Lomb, a global eye health company, has exercised its option to purchase all outstanding and unowned shares of Technolas Perfect Vision (TPV), a ophthalmology laser company based in Germany.

More... »